Home › Funds › Fund Evaluation Group, LLC › CATH
Fund Evaluation Group, LLC position in CATH
GLOBAL X FDS
Fund Evaluation Group, LLC reported holding 960,755 shares of CATH (GLOBAL X FDS) in its Q3 2026 13F filing — a position valued at US$87.1M, representing 2.06% of its reported portfolio and ranking #11 among its reported holdings. Fund Evaluation Group, LLC has disclosed CATH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Fund Evaluation Group, LLC's CATH position evolved
Fund Evaluation Group, LLC first disclosed a stake in CATH in Q3 2023 at 381,977 shares (US$20.0M). The position peaked in Q3 2026 at 960,755 shares, worth US$87.1M. Across 13 filings, Fund Evaluation Group, LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 960,755 shares valued at US$87.1M — a reduction of -15,728 shares quarter over quarter.. Notable position changes include a 30% increase in Q1 2025 (shares rose 12% over the following quarter), a 54% increase in Q3 2025 (shares rose 1% over the following quarter), a 32% increase in Q2 2026 (shares rose 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 381.98K | $19.98M | New |
| Q4 2023 | 380.70K | $22.08M | Hold |
| Q1 2024 | 387.02K | $24.63M | Add |
| Q2 2024 | 397.93K | $26.02M | Add |
| Q3 2024 | 298.49K | $20.71M | Reduce |
| Q4 2024 | 373.20K | $26.44M | Add |
| Q1 2025 | 486.37K | $32.85M | Add |
| Q2 2025 | 476.07K | $35.92M | Reduce |
| Q3 2025 | 733.24K | $59.44M | Add |
| Q4 2025 | 685.65K | $56.38M | Reduce |
| Q1 2026 | 738.46K | $57.71M | Add |
| Q2 2026 | 976.48K | $86.42M | Add |
| Q3 2026 | 960.75K | $87.12M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CATH and 13F data
CATH (GLOBAL X FDS) is a company whose sector is not yet classified in our data. 30 other funds we track also report a position in CATH — the largest reported positions include CENTRAL TRUST Co (US$42.4M), BCM ADVISORS, LLC (US$19.6M), Choate Investment Advisors (US$19.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CATH
- CENTRAL TRUST Co 468.03K sh · $42.44M · Q3 2026
- BCM ADVISORS, LLC 218.26K sh · $19.58M · Q3 2026
- Choate Investment Advisors 215.10K sh · $19.50M · Q3 2026
- COMMON FUND FOR NONPROFIT ORGANIZATIONS 121.01K sh · $10.71M · Q2 2026
- Sound View Wealth Advisors Group, LLC 97.19K sh · $8.81M · Q3 2026
- Security Financial Services, INC. 82.40K sh · $7.47M · Q3 2026
- First Bank & Trust 65.83K sh · $5.97M · Q3 2026
- DAGCO, INC. 65.00K sh · $5.89M · Q3 2026
More on Fund Evaluation Group, LLC
FAQ
How long has Fund Evaluation Group, LLC held CATH?
Fund Evaluation Group, LLC has disclosed CATH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Fund Evaluation Group, LLC's current position in CATH?
As of Q3 2026, Fund Evaluation Group, LLC holds 960.75K shares of CATH (GLOBAL X FDS), valued at $87.12M, representing 2.06% of its reported portfolio and ranking #11.
Has Fund Evaluation Group, LLC been buying or selling CATH?
In the latest 13F filing (Q3 2026), Fund Evaluation Group, LLC reduced its position in CATH. The position peaked in Q3 2026 at 960.75K shares.
Which other funds hold CATH?
Other major institutional holders of CATH include CENTRAL TRUST Co, BCM ADVISORS, LLC, Choate Investment Advisors, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.